Lifestyle Intervention for Myeloproliferative Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to see if patients with myeloproliferative disorders are able to successfully complete the Cardiac Lifestyle Program(CLP). The goal of the CLP is to teach patients how to become more active and eat healthier foods.The name of the intervention used in this research study is:Cardiac Lifestyle Program (a 12-week, tailored nutrition and physical activity program)
Who Is on the Research Team?
Gabriela Hobbs, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults over 18 with myeloproliferative disorders (like ET, PV, pre-MF, MF, or MPN-NOS) who are low to intermediate-1 risk. They should be fairly active (ECOG status 0-1) and have at least one cardiovascular risk factor such as being overweight or having high blood pressure, cholesterol issues, diabetes/pre-diabetes/metabolic syndrome, or a history of heart disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 12-week Cardiac Lifestyle Program involving exercise and nutrition
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cardiac Lifestyle Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor